Initial Statement of Beneficial Ownership (3)
July 11 2018 - 7:40PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wolk Joseph J
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
7/2/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
JOHNSON & JOHNSON [JNJ]
|
(Last)
(First)
(Middle)
ONE JOHNSON & JOHNSON PLAZA
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
Exec VP, CFO /
|
(Street)
NEW BRUNSWICK, NJ 08933
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
9576.4650
|
D
|
|
Common Stock
|
1775.0000
(1)
|
I
|
By 401k
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Options (Right to Buy)
(2)
|
1/17/2016
|
1/13/2023
|
Common Stock
|
1855.0000
|
$72.5400
|
D
|
|
Employee Stock Options (Right to Buy)
(2)
|
2/11/2017
|
2/9/2024
|
Common Stock
|
12926.0000
|
$90.4400
|
D
|
|
Employee Stock Options (Right to Buy)
(2)
|
2/10/2018
|
2/9/2025
|
Common Stock
|
13015.0000
|
$100.0600
|
D
|
|
Employee Stock Options (Right to Buy)
(2)
|
2/9/2019
|
2/8/2026
|
Common Stock
|
16820.0000
|
$101.8700
|
D
|
|
Employee Stock Options (Right to Buy)
(2)
|
2/13/2020
|
2/13/2027
|
Common Stock
|
19241.0000
|
$115.6700
|
D
|
|
Employee Stock Options (Right to Buy)
(2)
|
2/12/2021
|
2/11/2028
|
Common Stock
|
12066.0000
|
$129.5100
|
D
|
|
Restricted Share Units
(3)
|
2/8/2019
|
(3)
|
Common Stock
|
2540.0000
|
(3)
|
D
|
|
Restricted Share Units
(3)
|
2/12/2021
|
(3)
|
Common Stock
|
2543.0000
|
(3)
|
D
|
|
Restricted Share Units
(3)
|
2/13/2020
|
(3)
|
Common Stock
|
3400.0000
|
(3)
|
D
|
|
Explanation of Responses:
|
(1)
|
Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
|
(2)
|
Vested and exercisable one day after the third anniversary of the date of the grant.
|
(3)
|
Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Wolk Joseph J
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933
|
|
|
Exec VP, CFO
|
|
Signatures
|
Linda E. King, as attorney-in-fact for Joseph J. Wolk
|
|
7/11/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024